Jun 23, 2026
15 MIN READ

Is Wegovy or Saxenda Better for Weight Loss?

Both Wegovy and Saxenda are FDA-approved injectables for chronic weight management, but they work through different mechanisms and produce different results. Understanding their differences helps you make an informed choice about your weight loss journey.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jun 23, 2026
15 MIN READ

is wegovy or saxenda better for weight loss? — PlexusDx GLP-1 education

Last reviewed: June 23, 2026

Last updated: June 23, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Wegovy and Saxenda represent two distinct approaches to prescription weight loss therapy, each targeting different hormonal pathways in the brain and gut. While both medications help people lose significant weight, they differ in their active ingredients, dosing schedules, and clinical outcomes. PlexusDx offers compounded versions of these therapies at transparent, flat monthly prices that don't increase with dose adjustments.

How Wegovy and Saxenda Work Differently

Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics a natural hormone controlling hunger and blood sugar. Saxenda contains liraglutide, which is also a GLP-1 receptor agonist but with a different chemical structure and shorter half-life. Both medications slow gastric emptying—the rate your stomach releases food—and increase feelings of fullness, but semaglutide's longer-acting formulation means fewer weekly injections are needed.

The key distinction lies in potency and duration. Semaglutide remains active in your body for approximately seven days per injection, allowing for once-weekly dosing. Liraglutide, by contrast, requires daily injections because it clears from your system faster. This difference affects convenience, injection frequency, and how quickly your body reaches steady-state medication levels.

Clinical Efficacy: Weight Loss Results Compared

Clinical trials demonstrate that semaglutide (Wegovy) produces greater average weight loss than liraglutide (Saxenda). In the STEP trials, patients on semaglutide 2.4 mg weekly lost approximately 15% of their body weight over 68 weeks. Patients taking liraglutide 3.0 mg daily in the SCALE trial achieved approximately 8% weight loss over 56 weeks, a meaningful but more modest reduction.

These numerical differences translate to real-world outcomes: someone weighing 250 pounds might lose roughly 37 pounds on semaglutide versus 20 pounds on liraglutide, though individual results vary based on diet, exercise, and metabolic factors. The superiority of semaglutide's weight-loss effect has made it the more frequently prescribed option among healthcare providers seeking optimal patient outcomes.

Injection Frequency and Convenience Factors

Once-weekly semaglutide injections fit more easily into busy lifestyles compared to daily liraglutide administration. Missing a single weekly semaglutide dose has less impact on blood levels than missing a daily liraglutide injection. This convenience advantage may improve medication adherence, since studies show patients are more likely to stick with weekly versus daily regimens over months and years.

Daily injections also increase the cumulative needle-stick burden over time, which some patients find psychologically challenging or logistically inconvenient when traveling or managing multiple daily medications. The once-weekly format of semaglutide reduces this burden significantly, making it particularly appealing for people seeking simplicity in their weight management routine.

Cost Comparison and Access Through PlexusDx

Brand-name Wegovy and Saxenda carry substantial out-of-pocket costs when insurance doesn't cover them, often exceeding $900–$1,500 monthly depending on your pharmacy and dosing schedule. PlexusDx offers compounded semaglutide injections starting at $149 per month on a flat-rate basis—your dose may need to go up, but your price won't. This transparency eliminates surprise costs as you adjust to your optimal therapeutic dose.

PlexusDx delivers semaglutide through licensed 503A compounding pharmacies to all 50 states without requiring insurance or membership fees. HSA and FSA accounts cover compounded semaglutide, making it accessible to more patients than brand-name alternatives alone. For those seeking the established efficacy of semaglutide at a fraction of brand-name pricing, PlexusDx provides a straightforward, affordable pathway to treatment.

Side Effects and Tolerability Profiles

Both semaglutide and liraglutide produce similar gastrointestinal side effects—nausea, vomiting, constipation, and diarrhea—particularly during dose escalation. These effects typically diminish as your body adjusts over weeks. Semaglutide's higher potency sometimes correlates with more pronounced initial nausea in some patients, though this remains manageable through gradual dosing protocols and dietary adjustments.

Rare but serious concerns include pancreatitis, gallbladder issues, and thyroid complications, though these occur in very small percentages of users. Most patients tolerate both medications well once they reach their maintenance dose. Your healthcare provider can help you weigh individual risk factors and determine which medication aligns best with your medical history and tolerance profile.

Personalization Through Genetic Testing

Not every weight loss medication works equally well for every person, partly due to genetic variation in hunger-regulating pathways. PlexusDx offers the Precision Peptide Genetic Test, which analyzes 14 pathways and 49 peptides using variants like GLP1R rs6923761, GIPR rs1800437, and MC4R rs17782313 to reveal your individual peptide predispositions. This $99 add-on test (available after your first month of treatment) helps predict whether semaglutide or alternative compounds may suit your biology best.

Genetic insights from PlexusDx guide personalized dosing and compound selection, moving beyond one-size-fits-all approaches. Some patients show genetic markers suggesting superior response to semaglutide monotherapy, while others may benefit from dual-compound formulations like GLP-Squared (semaglutide plus tirzepatide). Understanding your genetic peptide profile empowers more targeted, effective treatment decisions.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Which is actually more effective for weight loss—Wegovy or Saxenda?

Semaglutide (Wegovy) produces approximately 15% average weight loss compared to liraglutide's (Saxenda) 8% in clinical trials, making semaglutide roughly twice as effective. Individual results vary based on genetics, diet, exercise, and adherence, but semaglutide's superior efficacy drives its popularity among prescribers and patients seeking maximum results.

Why does semaglutide work better than liraglutide?

Semaglutide's chemical structure allows stronger and longer-lasting GLP-1 receptor binding, creating a more potent appetite-suppressing effect and better blood sugar control. Liraglutide's shorter half-life and weaker receptor interaction mean it requires daily dosing and produces more modest metabolic effects, though it remains a legitimate treatment option for some patients.

Can I get semaglutide through PlexusDx instead of buying brand Wegovy?

Yes. PlexusDx compounded semaglutide injections start at $149 monthly from licensed 503A pharmacies, serving all 50 states without insurance requirements. Your dose may need to go up, but your price won't—offering the same active medication as Wegovy at a fraction of the brand-name cost.

Are compounded semaglutide and Wegovy equally safe?

Compounded semaglutide from licensed 503A pharmacies contains the same active pharmaceutical ingredient as Wegovy, manufactured to strict quality standards. Safety profiles are equivalent; side effects, contraindications, and monitoring requirements remain identical, though you should always inform your provider you're using compounded medication.

How can the Precision Peptide Genetic Test help me choose between these medications?

PlexusDx's $99 genetic test analyzes your GLP1R, GIPR, FTO, and MC4R variants across 14 pathways to reveal your individual peptide predispositions. Results predict whether semaglutide monotherapy or alternative compounds may work best for your genetics, supporting more personalized, effective treatment decisions beyond generic recommendations.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves